Security key
36269B105
- Security type / class
- Equity / COM
- Total 13F shares
- 3,541,963
- Total 13F value
- $6,489,816
- Share change
- +885,257
- Put/Call ratio
- 0%
- SEC-reported price per share
- $1.80
- Number of holders
- 34
- Value change
- +$1,630,740
- Number of buys
- 16
- Number of sells
- 9
Open additional details 1 more signal available
Report period
Q2 2025
Institutions
34
Top holders
10
GANX full security history
Ownership snapshot
Full 13F holder table
Gain Therapeutics, Inc. SEC filings
Gain Therapeutics, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of GANX - Gain Therapeutics, Inc. - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Gotham Asset Management, LLC
Disclosed value leader
Gotham Asset Management, LLC
Comparable rows
0/15
Latest evidence
24 Jun 2025
13F
3/4/5
Highest disclosed value: $3,173,610
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Gotham Asset Management, LLC has the largest disclosed position value at $3.17M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Gotham Asset Management, LLC's linked filing trail.
Disclosed position value
Top 5
Gotham Asset Management, LLC
$3.17M
Eric I. Richman
$1.17M
DME Capital Management, LP
$1.08M
JONES FINANCIAL COMPANIES LLLP
$808.4K
GEODE CAPITAL MANAGEMENT, LLC
$539.1K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Gotham Asset Management, LLC |
13F
Company
|
—
class O/S missing
|
$3,173,610
153,984 shares
|
— | 31 Mar 2025 |
| Eric I. Richman |
3/4/5
Director
|
—
mixed-class rows
|
$1,174,903
319,458 shares
mixed-class rows
|
— | 24 Jun 2025 |
| DME Capital Management, LP |
13F
Company
|
—
class O/S missing
|
$1,081,308
566,130 shares
|
— | 31 Mar 2025 |
| JONES FINANCIAL COMPANIES LLLP |
13F
Company
|
—
class O/S missing
|
$808,353
427,700 shares
|
— | 31 Mar 2025 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
class O/S missing
|
$539,085
282,211 shares
|
— | 31 Mar 2025 |
| VANGUARD GROUP INC |
13F
Company
|
—
class O/S missing
|
$487,031
254,990 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
34
Shares
3,541,963
Rows available
34
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
32
Q2 2025 holders
34
Holder diff
2
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|